Insider Selling: Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Sells 10,500 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hakan Kardes sold 10,500 shares of the stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $14.99, for a total transaction of $157,395.00. Following the completion of the sale, the insider now directly owns 309,944 shares in the company, valued at approximately $4,646,060.56. This represents a 3.28 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Hakan Kardes also recently made the following trade(s):

• On Wednesday, November 27th, Hakan Kardes sold 35,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.80, for a total transaction of $448,000.00.
• On Monday, November 4th, Hakan Kardes sold 20,500 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.06, for a total value of $267,730.00.
• On Friday, November 1st, Hakan Kardes sold 4,500 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.98, for a total value of $58,410.00.

Alignment Healthcare Stock Down 0.3 %

Shares of ALHC traded down $0.04 during trading hours on Thursday, hitting $14.57. The company had a trading volume of 1,177,627 shares, compared to its average volume of 1,850,902. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82. The company has a market capitalization of $2.79 billion, a PE ratio of -18.92 and a beta of 1.45. Alignment Healthcare, Inc. has a one year low of $4.46 and a one year high of $15.03. The company’s fifty day moving average price is $12.03 and its two-hundred day moving average price is $10.92.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Tuesday, October 29th. The company reported ($0.14) EPS for the quarter, meeting the consensus estimate of ($0.14). The business had revenue of $692.43 million during the quarter, compared to analyst estimates of $662.11 million. Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. The company’s quarterly revenue was up 51.6% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.19) earnings per share. As a group, equities analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on ALHC shares. Stifel Nicolaus lifted their target price on Alignment Healthcare from $14.00 to $16.00 and gave the stock a “buy” rating in a research report on Tuesday, January 14th. UBS Group lifted their price objective on shares of Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a report on Wednesday, October 30th. KeyCorp started coverage on shares of Alignment Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Stephens reiterated an “overweight” rating and issued a $17.00 price target on shares of Alignment Healthcare in a report on Thursday, January 2nd. Finally, Barclays raised their price objective on Alignment Healthcare from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, October 30th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, Alignment Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $11.88.

Hedge Funds Weigh In On Alignment Healthcare

A number of large investors have recently made changes to their positions in the business. Creative Planning increased its position in Alignment Healthcare by 20.0% during the 3rd quarter. Creative Planning now owns 12,442 shares of the company’s stock valued at $147,000 after buying an additional 2,072 shares in the last quarter. R Squared Ltd purchased a new stake in shares of Alignment Healthcare during the fourth quarter worth about $55,000. SG Americas Securities LLC grew its stake in shares of Alignment Healthcare by 11.7% during the fourth quarter. SG Americas Securities LLC now owns 49,272 shares of the company’s stock worth $554,000 after acquiring an additional 5,163 shares during the last quarter. nVerses Capital LLC acquired a new position in shares of Alignment Healthcare during the third quarter valued at about $95,000. Finally, The Manufacturers Life Insurance Company boosted its stake in Alignment Healthcare by 20.9% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 55,531 shares of the company’s stock worth $434,000 after purchasing an additional 9,595 shares in the last quarter. 86.19% of the stock is owned by institutional investors and hedge funds.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.